Pharmaceutical giant Johnson & Johnson has been ordered to pay $55 million to an American woman who says the company’s talcum powder caused her to develop ovarian cancer.
Following a three-week-long trial in Missouri, jurors decided on Monday in favor of Gloria Ristesund, Reuters reports. The 62-year-old plaintiff said she had used the company’s talc-based powders as feminine hygiene products for decades. According to her lawyers, she developed ovarian cancer and had to get a hysterectomy.
The decision follows a previous case in the same court in February, in which a family of a woman who died of ovarian cancer was awarded $72 million.
According to Reuters, the company is facing 1,2000 similar lawsuits, accusing the Johnson & Johnson of not adequately warning its consumers about the cancer risks to its talcum-based products, which include Baby Powder and Shower to Shower Powder.
J&J, reports Reuters, says its cosmetic talc is safe and that Monday’s verdict at the Missouri state court contradicts 30 years of research. The company intends to appeal the jury decision.
[Reuters]
- Global Climate Solutions Exist. It's Time to Deploy Them
- What Happens to Diane Feinstein's Senate Seat
- Who The Golden Bachelor Leaves Out
- Rooftop Solar Power Has a Dark Side
- How Sara Reardon Became the 'Vagina Whisperer'
- Is It Flu, COVID-19, or RSV? Navigating At-Home Tests
- Kerry Washington: The Story of My Abortion
- Want Weekly Recs on What to Watch, Read, and More? Sign Up for Worth Your Time
